載入...

Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization

In order to evaluate the effect of topical and subconjunctival anti-vascular endothelial growth factor (anti-VEGF) therapy, Ranibizumab, Bevacizumab and Aflibercept as a therapy for corneal neovascularization (NV) treatment, the aim of this study was to review all data related to some of anti-VEGF a...

全面介紹

Na minha lista:
書目詳細資料
發表在:Saudi J Ophthalmol
Main Authors: Al-Debasi, Tariq, Al-Bekairy, Abdulkareem, Al-Katheri, Abdulmalik, Al Harbi, Shmeylan, Mansour, Mahmoud
格式: Artigo
語言:Inglês
出版: Elsevier 2017
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436388/
https://ncbi.nlm.nih.gov/pubmed/28559722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjopt.2017.02.008
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!